4-nitrophenyl 2-fluoropropionate has been researched along with fibrinogen in 1 studies
| Studies (4-nitrophenyl 2-fluoropropionate) | Trials (4-nitrophenyl 2-fluoropropionate) | Recent Studies (post-2010) (4-nitrophenyl 2-fluoropropionate) | Studies (fibrinogen) | Trials (fibrinogen) | Recent Studies (post-2010) (fibrinogen) |
|---|---|---|---|---|---|
| 7 | 0 | 3 | 34,477 | 1,707 | 7,083 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goodman, SL; Haubner, R; Kessler, H; Mang, C; Schwaiger, M; Senekowitsch-Schmidtke, R; Weber, WA; Wester, HJ; Ziegler, SI | 1 |
1 other study(ies) available for 4-nitrophenyl 2-fluoropropionate and fibrinogen
| Article | Year |
|---|---|
Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography.
Topics: Animals; Azides; Biomarkers, Tumor; DNA-Binding Proteins; Female; Fibrinogen; Fluorine Radioisotopes; Galactose; Humans; Isotope Labeling; Melanoma; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Osteosarcoma; Peptides, Cyclic; Radiopharmaceuticals; Receptors, Vitronectin; Tissue Distribution; Tomography, Emission-Computed; Transcription Factors; Transplantation, Heterologous; Vitronectin | 2001 |